Novel Topical Treatment of Eczema

Information

  • Research Project
  • 7157258
  • ApplicationId
    7157258
  • Core Project Number
    R43AR052544
  • Full Project Number
    1R43AR052544-01A1
  • Serial Number
    52544
  • FOA Number
    PA-06-06
  • Sub Project Id
  • Project Start Date
    9/1/2006 - 18 years ago
  • Project End Date
    8/31/2008 - 16 years ago
  • Program Officer Name
    LAPHAM, CHERYL K.
  • Budget Start Date
    9/1/2006 - 18 years ago
  • Budget End Date
    8/31/2008 - 16 years ago
  • Fiscal Year
    2006
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    8/9/2006 - 18 years ago

Novel Topical Treatment of Eczema

[unreadable] DESCRIPTION (provided by applicant): Irritant and allergic contact dermatitis affect approximately 10% of adults, and hand eczema represents 1 of the 4 most common occupationally related diseases, accounting for substantial lost earning potential in otherwise healthy populations. Both irritant and allergic contact dermatitis is characterized by erythema and vesicles, as well as dry skin that demonstrate changes in the biophysical properties of the stratum corneum, especially with respect to the water permeability barrier. Recent research in dermatology has investigated treatments that focus on restoring barrier homeostasis for skin conditions including hypertrophic scars and keloids, inflammatory dermatoses such as atopic dermatitis and psoriasis, disorders of keratinization, and eczema. The goal of this project is to develop a novel topical vehicle to treat contact dermatitis/eczema. The Specific Aims of the Research Plan are to optimize a novel coating formulation to include physiologic lipids, and then evaluate the optimized coatings in a prospective, randomized, double-blind left/right comparative clinical trial involving patients with hand eczema. Hand eczema is the most common occupational skin disease and affects a large population of those of working age. Hand eczema is common in professions such as mechanics, textile workers, hair dressers, and especially healthcare workers. In healthcare personnel, hand dermatitis including redness, dryness, and cracking occurs regularly (18.3%-72.9%) as a consequence to frequent hand washing, antisepsis techniques, and chronic occlusion from gloving. Damaged hands increase the risk of colonization of microorganisms on the skin and deter hand washing, and also provide a route for skin sensitization to natural rubber latex proteins. Notably, a positive correlation between the clinical diagnoses of latex protein allergy with pre-existing hand eczema (82%) has been shown. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R43
  • Administering IC
    AR
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    134645
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
    NIAMS:134645\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BIOMEDICAL DEVELOPMENT CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN ANTONIO
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    782163610
  • Organization District
    UNITED STATES